Established in 2006, BioFirst Corporation is Cordedicated to research,develop, manufacturing, and marketing of innovative patented medical products.
BioFirst licenses- in technologies from local research organizations with exclusive global right. Vitreous Substitute is our most advanced R&D product licensed from National Health Research Institutes (NHRI).

Biofirst recruited one R&D expert who was out of hold the inventor original patent to join our R&D team to effectively continue the work of technologies and products in our lab. The majority of manufacturing process, specification, QC, and formulation development have been completed by our team members. Primary cell experiments and animal studies were also completed internally.